AssayIndex

MKM-2505-M4185

AOD-9604 · 5 mg declared · Xi'an Mokemei Biotechnology Co., Ltd. · manufactured 07 May 2025

CHARACTERISED
Lot code
MKM-2505-M4185
Supplier
MKM — Xi'an Mokemei Biotechnology Co., Ltd.
Compound
AOD-9604
Compound class
Metabolic and mitochondrial peptides
Declared label claim
5mg
Manufacture date
07 May 2025
Index quarter
2025-Q2
Independent assays
8
Laboratories involved
Medutest, VendorInvestigate, Janoshik, PeptideMeter
Provenance mix
Buyer-sourced ×2 · Supplier-supplied ×6
Section 1

Reproducibility across independent tests

Every report below is an observation of the same physical material. What they disagree about is measurement; what they agree about is the lot. The size of the disagreement is compared against what the contributing laboratories' own repeatability figures predict.

Independent assays 8
Median purity 98.95% n=8
Spread (max − min) 1.73pp n=8
Standard deviation 0.698pp n=8
96.997.498.098.599.199.6100.2This lot (MKM-2505-M4185)This lot (MKM-2505-M4185): Q1 98.34, median 98.95, Q3 99.11, n=8n=8All AOD-9604All AOD-9604: Q1 98.81, median 99.25, Q3 99.74, n=89outlier 97.11n=89 Purity (% area)
Figure 1. This lot's independent purity results against the whole AOD-9604 record set in the index. The vertical line is the index acceptance specification for the metabolic and mitochondrial peptides class, 98.0 % area. A narrow box on the top row against a wide box on the bottom row is the ideal reading: it means the disagreement between lots is much larger than the disagreement within this one.
Section 2

Member reports 8

Every report the index holds on this lot. Each is a page carrying its own chromatogram, mass spectrum, mass balance, provenance and caveats.

ReportLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2025-020387MKM-2505-M4185Medutest2025-Q299.255.53Supplier-supplied1MARGINAL
AX-2025-020388MKM-2505-M4185Medutest2025-Q299.096.45Supplier-supplied1MARGINAL
AX-2025-020389MKM-2505-M4185VendorInvestigate2025-Q297.595.8699.0Buyer-sourced0FAIL
AX-2025-020390MKM-2505-M4185Janoshik2025-Q298.815.78Supplier-supplied1MARGINAL
AX-2025-020391MKM-2505-M4185VendorInvestigate2025-Q297.525.8496.1Buyer-sourced0FAIL
AX-2025-020392MKM-2505-M4185Janoshik2025-Q298.596.02Supplier-supplied1MARGINAL
AX-2025-020393MKM-2505-M4185PeptideMeter2025-Q299.106.51Supplier-supplied1MARGINAL
AX-2025-020394MKM-2505-M4185Medutest2025-Q299.135.65Supplier-supplied1MARGINAL
Section 3

By laboratory

Where more than one laboratory assayed this lot, the difference between them is a paired observation of their relative bias — the same material, the same time window, different instruments. Those pairs are what the index's bias estimates are built from.

LaboratoryReportsPurity results (% area)MedianGradientPublished bias (pp)Bias-adjusted
Medutest399.25, 99.09, 99.1399.1325min+0.0899.05
VendorInvestigate297.59, 97.5297.5632min-0.1197.67
Janoshik298.81, 98.5998.7030min+0.0098.70
PeptideMeter199.1099.1028min-0.0599.15

This lot contributes 6 paired comparisons to the inter-lab analysis.

Section 4

The supplier's certificate for this lot

One number the supplier wrote, beside the median of the numbers other people measured on the same physical material. That comparison is only available because the index groups by lot.

FigureSupplier COAThis reportIndex note
Purity (% area)98.8999.25divergence -0.06 pp vs batch median
Total impurities (% area)1.110.75
Largest single impurity (% area)not stated0.28
Water (%)4.05.53
Counter-ion (%)not stated4.46
Peptide content (%w/w)91.2not determined
Endotoxin (EU/mg)not stated0.70
Method stated on certificateNOno method section — the result cannot be reconciled against any other
Section 5

Impurity fingerprint

The named impurities reported across this lot's assays, with how consistently each was seen. A fingerprint is what allows two lot numbers held by different companies to be identified as one bulk.

Named impurityReported inMedian % areaRange
open-chain (reduced disulfide, +2 Da)8 / 80.710.28–0.95
AOD dimer8 / 80.140.05–0.63
des-Tyr AOD (−163 Da)8 / 80.160.11–0.50
Met sulfoxide (+16 Da)8 / 80.160.12–0.43
Section 7

What this rollup does not establish